Pulmovant
1 follower
Pulmovant is a clinical-stage biotechnology company developing innovative therapies for patients suffering from pulmonary diseases. Pulmovant’s first program, mosliciguat is designed to provide an effective, once-daily, inhaled treatment option for patients with pulmonary hypertension (PH). Moslicig... Read more
Org chart
Drew Fromkin
Chief Executive Officer
Collapse
Joe Bishop
Chief Financial Officer
Carlos Sanmarco
Chief Operating Officer
Brian Schlag
Senior Vice President, Head of Regulatory Affairs and Quality
Ubaldo J. Martin MD
Senior VP, Head of Clinical Development
Teams
This company has no teams yet